18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature

• Published in: Journal of imaging 2023-10, Vol.9 (10), p.223
• Main Authors: Allahqoli, Leila, Hakimi, Sevil, Laganà, Antonio Simone, Momenimovahed, Zohre, Mazidimoradi, Afrooz, Rahmani, Azam, Fallahi, Arezoo, Salehiniya, Hamid, Ghiasvand, Mohammad Matin, Alkatout, Ibrahim
• Format: Article
• Language: English
• Subjects: 18F-FDG PET/CT; 18F-FDG PET/MRI; Accuracy; Cancer; Computed tomography; Criteria; CT imaging; Data collection; Diagnosis; Endometrial cancer; Fluorine; Fluorine isotopes; Genital cancer; gynecologic malignancies; Gynecology; hybrid FDG PET/MRI; imaging; Literature reviews; Lymphatic system; Magnetic resonance imaging; Medical diagnosis; Medical imaging; Metastasis; Mutation; Oncology, Experimental; Ovarian cancer; PET imaging; Positron emission; Review; Systematic review; Tomography; Womens health
• ISSN: 2313-433X; 2313-433X
• DOI: 10.3390/jimaging9100223

Objective: Positron emission tomography with 2-deoxy-2-[fluorine-18] fluoro- D-glucose integrated with computed tomography (18F-FDG PET/CT) or magnetic resonance imaging (18F-FDG PET/MRI) has emerged as a promising tool for managing various types of cancer. This review study was conducted to investigate the role of 18F- FDG PET/CT and FDG PET/MRI in the management of gynecological malignancies. Search strategy: We searched for relevant articles in the three databases PubMed/MEDLINE, Scopus, and Web of Science. Selection criteria: All studies reporting data on the FDG PET/CT and FDG PET MRI in the management of gynecological cancer, performed anywhere in the world and published exclusively in the English language, were included in the present study. Data collection and analysis: We used the EndNote software (EndNote X8.1, Thomson Reuters) to list the studies and screen them on the basis of the inclusion criteria. Data, including first author, publication year, sample size, clinical application, imaging type, and main result, were extracted and tabulated in Excel. The sensitivity, specificity, and diagnostic accuracy of the modalities were extracted and summarized. Main results: After screening 988 records, 166 studies published between 2004 and 2022 were included, covering various methodologies. Studies were divided into the following five categories: the role of FDG PET/CT and FDG-PET/MRI in the management of: (a) endometrial cancer (n = 30); (b) ovarian cancer (n = 60); (c) cervical cancer (n = 50); (d) vulvar and vagina cancers (n = 12); and (e) gynecological cancers (n = 14). Conclusions: FDG PET/CT and FDG PET/MRI have demonstrated potential as non-invasive imaging tools for enhancing the management of gynecological malignancies. Nevertheless, certain associated challenges warrant attention.